A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

Research finds that a single dose of LSD can alleviate the symptoms of anxiety in those who do not find relief from other current treatments ...

Encouraging outcomes from a clinical study on the LSD-analog substance MM120, or lysergide d-tartrate, have led the Food and Drug Administration (FDA) to designate it as a “breakthrough therapy” for ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Catalent shows Catalent's MindMed's formulation of LSD. (Catalent via AP) WASHINGTON (AP) — LSD reduced ...

MindMed's LSD tartrate receives breakthrough therapy designation from the FDA for the treatment of generalized anxiety disorder. GAD affects a significant portion of the US population, with high costs ...

MindMed Inc. said Tuesday it’s on track to launch Phase 3 clinical trials with up to 440 people starting later this year for its treatment of generalized anxiety disorder (GAD) through use of ...

It’s no secret that Donald Trump is an egomaniac. That's pretty much a bipartisan belief. He’s been called a narcissist by more psychologists than you can shake a stick at. He’s obsessed with his TV ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

“While prior research has documented the benefits of combining LSD with psychotherapy to alleviate anxiety associated with life-threatening conditions, this groundbreaking study is the first to show ...